EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Development of a Versatile Lipid Core for Nanostructured Lipid Carriers (NLCs) Using Design of Experiments (DoE) and Raman Mapping

Carlos Alberto Rios, Roberta Ondei iD, Márcia Cristina Breitkreitz iD

Pharmaceutics · 08.02.2024 · 16 (2) · 250

DOI: 10.3390/pharmaceutics16020250 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 08.02.2024. Verfasst von Carlos Alberto Rios und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Chemistry, University of Campinas (UNICAMP), Rua Josué de Castro, s/n, Campinas 13084-971, SP, Brazil. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Coordenação de Aperfeicoamento de Pessoal de Nível Superior, Croda, INCT Bioanalitica.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The objective of this study was to develop a versatile lipid core for the ‘brick-dust type of drugs’ (poorly water-soluble and poorly lipid-soluble drugs). In the first step, excipients of different polarities were classified according to their behavior in aqueous solutions. Subsequently, binary mixtures were prepared with cetyl palmitate (Crodamol™ CP pharma, Campinas, São Paulo, Brazil) as the solid lipid, and its miscibility with other excipients was evaluated using Raman mapping and classical least squares (CLS). Based on the results, the excipients Crodamol™ CP pharma (hydrophobic), Super Refined™ DMI (dimethyl isosorbide; hydrophilic, Mill Hall, PA, USA), and Super Refined™ Lauryl Lactate (lauryl lactate, medium polarity, Mill Hall, PA, USA) were chosen to compose the lipid core. The ideal proportion of these excipients was determined using a mixture design and the standard deviation (STD) of image histograms as the response variables. After statistical evaluation of the DoE results, the final composition was determined, and drugs with different logP (0 to 10) and physicochemical characteristics were evaluated in the optimized mixture. The drugs butamben (Sigma-Aldrich Co., Spruce Street, St. Louis, MO, USA), tacrolimus (NutriFarm, São Paulo, Brazil), atorvastatin calcium, and resveratrol (Botica da Terra, Campinas, Brazil) presented a homogeneous distribution in the optimized lipid core, indicating that this is a promising system to be used in nanostructured lipid carrier (NLC) formulations of such types of drugs.

Schlagwörter

Stichwörter der Autor:innen

Raman imagingclassical least squaresdesign of experimentnanostructured lipid carriers

Autor:innen und Institutionen

  • Institute of Chemistry, University of Campinas (UNICAMP), Rua Josué de Castro, s/n, Campinas 13084-971, SP, Brazil.
  • Croda Brazil, R. Croda, 580-Distrito Industrial, Campinas 13054-710, SP, Brazil.

ORCID-Profile: Roberta Ondei, Márcia Cristina Breitkreitz

Förderung

  • Coordenação de Aperfeicoamento de Pessoal de Nível Superior
  • Croda
  • INCT Bioanalitica
  • CAPES
  • CNPq/FAPESP

Zitieren

APA

Rios, C. A., Ondei, R., & Breitkreitz, M. C. (2024). Development of a Versatile Lipid Core for Nanostructured Lipid Carriers (NLCs) Using Design of Experiments (DoE) and Raman Mapping. Pharmaceutics, 16(2), 250. https://doi.org/10.3390/pharmaceutics16020250

Vancouver

Rios CA, Ondei R, Breitkreitz MC. Development of a Versatile Lipid Core for Nanostructured Lipid Carriers (NLCs) Using Design of Experiments (DoE) and Raman Mapping. Pharmaceutics. 2024;16(2):250. doi:10.3390/pharmaceutics16020250

BibTeX
@article{Rios2024,
  author = {Rios, Carlos Alberto and Ondei, Roberta and Breitkreitz, Márcia Cristina},
  title = {Development of a Versatile Lipid Core for Nanostructured Lipid Carriers (NLCs) Using Design of Experiments (DoE) and Raman Mapping},
  journal = {Pharmaceutics},
  year = {2024},
  volume = {16},
  number = {2},
  pages = {250},
  doi = {10.3390/pharmaceutics16020250}
}
Kostenlos starten →